pISSN: 1229-6538
eISSN: 2383-5699
search for




 

Cancer History and Age-Related Macular Degeneration: Age Appears to be an Influential Factor
Korean J Geriatr Gerontol 2024 Aug;25(2):99-104
Published online August 30, 2024;  https://doi.org/10.15656/kjgg.2024.25.2.99
Copyright © 2024 The Korean Academy of Geriatrics & Gerontology.

Jae Hyuck Lee1 , In Cheol Hwang1 , Yoo Jeong Lee2 , Hong Yup Ahn3

1Department of Family Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon; 2Department of Family Medicine, Korea University Guro Hospital, Seoul; 3Department of Statistics, Dongguk University, Seoul, Korea
Correspondence to: In Cheol Hwang, Department of Family Medicine, Gil Medical Center, 21 Namdong-daero, Namdong-gu, Incheon 21565, Korea. E-mail: spfe0211@gmail.com; or Yoo Jeong Lee, Department of Family Medicine, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea. E-mail: juujeong@naver.com
*These authors contributed equally to this work as corresponding authors.
Received May 3, 2024; Revised May 27, 2024; Accepted June 5, 2024.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Background: Both cancer and neurodegenerative disease impose significant burden on the daily lives of older adults. Interestingly, previous studies have observed an inverse association between cancer and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. This study evaluated the association between a history of cancer and the prevalence of age-related macular degeneration (AMD), a neurodegenerative disease affecting the retina, among cancer survivors.
Methods: Using data from the Korean National Health and Nutrition Examination Survey (KNHANES 2017-2018), we selected the data of 6,993 adults, including 452 cancer survivors, that had received and ophthalmic examination. A multivariate logistic regression model adjusted for potential covariates was used to investigate the association between cancer history and AMD prevalence.
Results: Participants with a cancer history were less likely to have AMD, but this relation was not significant. However, age-stratified analysis revealed that the prevalence of AMD tended to be lower only among young cancer survivors aged <55 years (P=0.076).
Conclusion: An inverse association between cancer and AMD might exist in young individuals. These findings highlight the potential importance of considering age-specific effects in the study of comorbidities between cancer and neurodegenerative diseases. Further research with large sample sizes and longitudinal data is warranted to confirm these observations and elucidate underlying mechanisms.
Keywords : Age-related macular degeneration, Cancer survivor, Neoplasm, Neurodegenerative disease
INTRODUCTION

With the aging of the population, there is a simultaneous rise in the burden of diverse age-related diseases. Among these, cancer and neurodegenerative diseases prominently influence various aspects of life in older adults. The diagnosis and treatment of cancer result in physical burdensomeness and psychosocial and economic adversities [1]. Likewise, neurodegenerative disease such as Alzheimer’s disease (AD) and Parkinson’s disease can profoundly impact daily lives. These conditions affect both cognitive function and motor skills, leading to difficulties in performing routine tasks, maintaining independence, and engaging in social activities [2,3].

Interestingly, solid evidence indicates an inverse association between the occurrence of cancer and neurodegenerative diseases, suggesting that individuals diagnosed with cancer have a reduced tendency to develop neurodegenerative diseases, while those with neurodegenerative diseases exhibit a diminished susceptibility to cancer [4,5]. One potential explanation revolves around the differing biological mechanisms present in each condition [6]. Cancer is characterized by uncontrolled cell proliferation, whereas neurodegenerative diseases typically involve programmed cell death known as apoptosis [7]. The reason for the inverse correlation is due to the occurrence of mechanisms is opposing directions.

Age-related macular degeneration (AMD) is a neurodegenerative disease affecting the retina and stands as a primary cause of visual impairment and severe loss of vision [8]. AMD shares features with AD, particularly in its relation with the accumulation of amyloid b [9]. In a cohort study conducted within the population of Finland, the study identified a correlation between visual impairment, including AMD, and cancer [10]. Nonetheless, the study focused exclusively on participant with visual impairment. A prospective cohort study found the AMD was linked with cancer mortality, but not incidence of cancer [11]. However, researches have predominantly focused on visual impairment of mortality, with few studies investigating the association between prevalence of AMD and cancer survivorship. Therefore, we aimed to evaluate the association between cancer history and the prevalence of AMD in a nationally representative Korean cohort.

MATERIALS AND METHODS

1. Design and participants

The data used was obtained from the Korean National Health and Nutrition Examination Survey (KNHANES 2017-2018), which addressed the prevalence of AMD, as determined by ophthalmologic examinations, using a newly generated variable (E-AMD). KNHANES is a nationwide population-based survey conducted annually by the Korean Ministry of Health and Welfare on subjects randomly selected using a stratified, multistage, probability sampling design. Interview and examinations were conducted in specially designed and equipped mobile centers. All subjects that participated in KNHANES provided written informed consent. More detailed information on KNHANES has already been published [12]. In this study, a final dataset of 6,993 participants aged ≥40 years that provided information on AMD, were included in the analysis (Figure 1). The study received approval form the Institutional Review Board of Gachon University Gil Medical Center, in accordance with established ethical standards (IRB no. GFIRB2021-481).

Figure 1. Flow diagram illustrating participant selection

2. Ophthalmic variables

AMD was identified through screening tests. AMD was defined based on the ophthalmologic examinations performed by certificated ophthalmologists, and the Epidemiologic Survey Committee of the Korean Ophthalmologic Society verified the quality of the ophthalmic surveys [13]. Ophthalmologic examinations included measurements of visual acuity and intraocular pressure, autorefraction, slit-lamp biomicroscopy, and fundus photography. Digital fundus photographs centered on the fovea (Diabetic Retinopathy Study standard field 2) were taken with a non-mydriatic fundus camera (TRC-NW6S, Topcon, Tokyo, Japan; Nikon D-80, Nikon, Tokyo, Japan) under physiological mydriasis. The examinations results classified AMD into Yes/No categories. Hyperopia, a common refractive error in which distant objects are seen more clearly than near objects due to the light rays entering the eye being focused behind the retina, was defined as a refractory error >+0.5 D [14]. A history of cataract surgery was determined using self-reported questionnaires. Conditions were considered present when one or both eyes were affected.

3. Other variables

Health interviews and health examinations were performed during a single day by trained medical staff and interviewers. Information on age, sex, health behaviors (smoking history, alcohol drinking, and physical activity), histories of physician-diagnosed diseases (any cancer, myocardial infarction, stroke, hypertension, and type 2 diabetes) were collected during interviews. Current smokers were defined as individuals who smoked cigarettes at the time of interview. Frequent drinking was defined as drinking twice per week. Regular exercise was defined ≥2.5 hours/week of moderate-intensity activity, ≥1.25 hours/week of high-intensity activity, or a considered combination of activities. After each interview, body height and weight were measured using a standard scale with participants wearing light clothing and no shoes, and body mass index (BMI) was calculated by dividing weight by height squared (kg/m2). Obesity was defined as BMI ≥25.0 kg/m2 according to WHO criteria for the Asia-Pacific region [15].

4. Statistical analysis

Demographics and clinical characteristics of participants were assessed using Chi-square test. A multiple logistic regression model adjusted for potential confounding factors, extracted by stepwise multivariate logistic regression analysis, was used to evaluate associations between cancer history and AMD prevalence. We determined the prevalence of AMD with 95% confidence intervals (CIs) by cancer history in the whole cohort and in age subgroups (40-54, 55-64, and ≥65 years old). All statistical analyses were performed using Stata/MP software (version 17.0; Stata Corp., College Station, TX, USA). All statistical tests were two-tailed, and statistical significance was accepted for P-value <0.05.

RESULTS

The demographics and clinical characteristics of participants are presented in Table 1. Among the 6,993 participants, 43.4% (n=3,038) were male. Individuals under the age of 55 comprised 39.2% (n=2,743), whereas those aged 65 and older represented 33.1% (n=2,312). Hyperopia was observed in 56.7% (n=3,965) of the participants, while 12.5% (n=873) had undergone cataract surgery. History of cancer was identified in 6.5% (n=452) and AMD was found in 16.0% (n=1,118).

Table 1 . Demographics and clinical characteristics of participants.

N (%)
Sex
Male3,038 (43.4)
Female3,955 (56.6)
Age
40-552,743 (39.2)
55-641,938 (27.7)
≥652,312 (33.1)
Body mass index ≥25 kg/m2
No4,445 (63.6)
Yes2,548 (36.4)
Smoking status
Non- or ex-smoker5,790 (83.3)
Current smoker1,157 (16.7)
Drinking frequency
<2 per week4,593 (75.2)
≥2 per week1,516 (24.8)
Aerobic exercise*
No4,140 (61.9)
Yes2,548 (38.1)
Hypertension
No4,771 (68.2)
Yes2,222 (31.8)
Type 2 diabetes
No6,153 (88.0)
Yes840 (12.0)
Major cardiovascular diseases
No6,699 (95.8)
Yes294 (4.2)
Hyperopia
No3,028 (43.3)
Yes3,965 (56.7)
Cataract surgery
No6,120 (87.5)
Yes873 (12.5)
Cancer history
No6,541 (93.5)
Yes452 (6.5)
AMD
No5,875 (84.0)
Yes1,118 (16.0)

AMD, age-related macular degeneration..

*≥2.5 Hours/week moderate intensity activity, ≥1.25 hours/week high-intensity activity or a considered combination of activities. Including myocardial infarction and stroke..



Table 2 shows age-adjusted prevalence of AMD by subject characteristic. Male sex, frequent drinking, and history of hyperopia were linked with a higher prevalence of AMD. Factors associated with AMD were detailed in Table 3. Older age (OR, 1.06; P<0.001), male sex (OR, 1.26; P=0.003), and hyperopia (OR, 1.55; P<0.001) were associated with AMD.

Table 2 . Age adjusted prevalence of AMD by participant charac-teristics.

AMD prevalence (95% CI)P-value*
Sex
Male14.8 (13.6-16.2)0.001
Female12.2 (11.2-13.3)
Body mass index ≥25 kg/m2
No13.9 (12.8-15.0)0.100
Yes12.5 (11.2-13.9)
Smoking status
Non- or ex-smoker13.0 (12.1-14.0)0.060
Current smoker15.2 (13.1-17.6)
Drinking frequency
<2 per week11.9 (10.9-12.9)0.043
≥2 per week13.8 (12.1-15.7)
Aerobic exercise
No13.1 (12.0-14.2)0.559
Yes13.6 (12.2-15.0)
Hypertension
No13.2 (12.2-14.3)0.599
Yes13.7 (12.3-15.2)
Type 2 diabetes
No13.4 (12.5-14.4)0.550
Yes12.8 (10.9-15.0)
Major cardiovascular diseases
No13.5 (12.6-14.4)0.083
Yes10.7 (8.1-13.9)
Hyperopia
No11.0 (9.9-12.3)<0.001
Yes15.0 (13.8-16.3)
Cataract surgery
No13.3 (12.4-14.2)0.638
Yes13.8 (11.8-16.1)
Cancer history
No13.4 (12.5-14.3)0.681
Yes12.8 (10.3-15.8)

AMD, age-related macular degeneration; CI, confidence interval..

*From multivariate logistic regression models. ≥2.5 Hours/week moderate intensity activity, ≥1.25 hours/week high-intensity activity or a considered combination of activities, as suggested by KNHANES. Including myocardial infarction and stroke..



Table 3 . Factors associated with AMD.

Odds ratio (95% CI)P-value*
Age1.06 (1.06-1.07)<0.001
Male sex1.26 (1.08-1.46)0.003
Hyperopia1.55 (1.29-1.85)<0.001

AMD, age-related macular degeneration..

*From multivariate logistic regression models with stepwise selection..



Figure 2 presents AMD prevalence by cancer history after adjusting for the selected variables in the 6,993 participants and the three age subgroups. Participants with a cancer history were found to be less likely to have AMD, though this was not significant (P=0.62). However, age-stratified analysis revealed that cancer history tended to be associated with low prevalence of AMD among young subjects (Ptrend=0.076).

Figure 2. Association between cancer history and AMD by age group. AMD, age-related macular degeneration. *Adjusted for age, sex, and hyperopia
DISCUSSION

In this nationally representative study, we investigated whether the association between a history of cancer and prevalence of AMD was significant in middle-aged and older adults. Our finding suggests that while this association was not remarkable in older adults, a potential reduction in AMD risk among cancer survivors may be influential in the younger population. Another robustness of our study was conducting an age-stratified analysis, which enabled us to discern the correlation between cancer and AMD across different age groups. A larger-scale study with adequate statistical power, particularly in younger individuals, is needed to refute or confirm our findings. The strength of our study resided in the accurate ophthalmic assessments rather than dependence on ICD codes.

Among participants younger than 55 years old, an inverse association between cancer and AMD was observed. A meta-analysis study further confirmed the inverse correlation between neurodegenerative diseases such as AD and Parkinson’s disease, and cancer occurrence [16]. Notably, a significant interaction was found between genes exhibiting upregulation in such neurodegenerative disorders and downregulation in cancers, as well as genes demonstrating downregulation in neurodegenerative disorders and upregulation in cancer [17]. Cancer is defined by uncontrolled cell proliferation, while neurodegenerative diseases often entail apoptosis, leading to an inverse relationship attributed to mechanisms functioning in divergent pathways. However, due to the multifactorial nature of factors influencing occurrence of cancer and AMD, further analysis is needed to determine which factors exert greater effect depending on age.

In our age-stratified analysis, we observed a simultaneous increase in the occurrence of both cancer and AMD among participants aged 65 and over, although statistical significance was not observed. A retrospective outpatient cohort study of US veterans reported a higher risk of AMD in people with a cancer history (hazard ratio, 1.37; CI, 1.36-1.39) than in those without [18]. Their study cohort comprised patients aged ≥65 years and older—corresponds to our oldest group, and their findings parallel our own results. This could be attributed to the fact that both cancer and AMD are linked with the aging process. Moreover, cancer and AMD exhibit overlapping risk factors. For instance, alcohol consumption has been identified as a prominent risk factor for both cancer and AMD [19]. Smoking, inflammation-related genes, and oxidative stress have also been identified as shared risk factors [11,20]. These findings imply the potential presence of shared pathogenic mechanisms between AMD and cancer.

Several limitations of the present study should be acknowledged. First, our study confirmed the history of cancer without categorizing cancer type. A population-based cohort study discovered variations in the occurrence of AMD depending on the type of cancer [21]. Hence, additional research is warranted based on the specific types of cancer. Second, the cross-sectional design could not resolve the issue of selective mortality. However, if cancer patients, who might have a lower risk of AMD, are more likely to die before they can develop AMD, this would rather have biased our results toward the null. A prospective cohort study with frequent examinations designed to timely detect cancer or AMD is warranted. Third, AMD was identified through screening tests rather than confirmatory diagnostics. Further research should focus on accurate diagnosis using confirmatory tests. Lastly, information on cancer treatment were unavailable for assessment, potentially confounding our findings due to the unknown influence of cancer treatments on AMD risk [22].

Nonetheless, our exploratory results support the possibility of an inverse relation between a history of cancer and AMD, as determined through precise ophthalmic examination. Thus, our findings suggest that a cancer history or vulnerability to cancer may protect younger individuals from neurodegenerative disease.

FUNDING

This research was supported by Gachon University Gil Medical Center under Grant FRD2021-14.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

References
  1. Essue BM, Iragorri N, Fitzgerald N, de Oliveira C. The psychosocial cost burden of cancer: a systematic literature review. Psychooncology 2020;29:1746-60.
    Pubmed KoreaMed CrossRef
  2. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CETeunissen CE, et al. Alzheimer's disease. Lancet 2021;397:1577-90.
    Pubmed CrossRef
  3. Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet 2021;397:2284-303.
    Pubmed CrossRef
  4. Seddighi S, Houck AL, Rowe JB, Pharoah PDP. Evidence of a causal association between cancer and Alzheimer's disease: a Mendelian randomization analysis. Sci Rep 2019;9.
    Pubmed KoreaMed CrossRef
  5. Ording AG, Horváth-Puhó E, Veres K, Glymour MM, Rørth M, Sørensen HTSørensen HT, et al. Cancer and risk of Alzheimer's disease: small association in a nationwide cohort study. Alzheimers Dement 2020;16:953-64.
    Pubmed KoreaMed CrossRef
  6. Tabarés-Seisdedos R, Rubenstein JL. Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nat Rev Neurosci 2013;14:293-304.
    Pubmed CrossRef
  7. Hanoun M, Maryanovich M, Arnal-Estapé A, Frenette PS. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron 2015;86:360-73.
    Pubmed KoreaMed CrossRef
  8. Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet 2018;392:1147-59.
    Pubmed CrossRef
  9. Ashok A, Singh N, Chaudhary S, Bellamkonda V, Kritikos AE, Wise ASWise AS, et al. Retinal degeneration and Alzheimer's disease: an evolving link. Int J Mol Sci 2020;21:7290.
    Pubmed KoreaMed CrossRef
  10. Pukkala E, Verkasalo PK, Ojamo M, Rudanko SL. Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control 1999;10:13-20.
    Pubmed CrossRef
  11. Cheung N, Shankar A, Klein R, Folsom AR, Couper DJ, Wong TY; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Age-related macular degeneration and cancer mortality in the atherosclerosis risk in communities study. Arch Ophthalmol 2007;125:1241-7.
    Pubmed CrossRef
  12. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi SChoi S, et al. Data resource profile: the Korea national health and nutrition examination survey (KNHANES). Int J Epidemiol 2014;43:69-77.
    Pubmed KoreaMed CrossRef
  13. Yoon KC, Mun GH, Kim SD, Kim SH, Kim CY, Park KHPark KH, et al. Prevalence of eye diseases in South Korea: data from the Korea national health and nutrition examination survey 2008-2009. Korean J Ophthalmol 2011;25:421-33.
    Pubmed KoreaMed CrossRef
  14. Ip JM, Robaei D, Kifley A, Wang JJ, Rose KA, Mitchell P. Prevalence of hyperopia and associations with eye findings in 6- and 12-year-olds. Ophthalmology 2008;115:678-85.e1.
    Pubmed CrossRef
  15. Oh SW. Obesity and metabolic syndrome in Korea. Diabetes Metab J 2011;35:561-6.
    Pubmed KoreaMed CrossRef
  16. Ibáñez K, Boullosa C, Tabarés-Seisdedos R, Baudot A, Valencia A. Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet 2014;10.
    Pubmed KoreaMed CrossRef
  17. Lanni C, Masi M, Racchi M, Govoni S. Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways. Mol Psychiatry 2021;26:280-95.
    Pubmed CrossRef
  18. Frain L, Swanson D, Cho K, Gagnon D, Lu KP, Betensky RABetensky RA, et al. Association of cancer and Alzheimer's disease risk in a national cohort of veterans. Alzheimers Dement 2017;13:1364-70.
    Pubmed KoreaMed CrossRef
  19. Kuan V, Warwick A, Hingorani A, Tufail A, Cipriani V, Burgess SBurgess S, et al; International AMD Genomics Consortium (IAMDGC). Association of smoking, alcohol consumption, blood pressure, body mass index, and glycemic risk factors with age-related macular degeneration: a Mendelian randomization study. JAMA Ophthalmol 2021;139:1299-306.
    Pubmed KoreaMed CrossRef
  20. Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration--what is the cause? Retina 2003;23:595-614.
    Pubmed CrossRef
  21. Park J, Jung W, Han K, Kim B, Lee SY, Yoon JMYoon JM, et al. Association between age-related macular degeneration and risk of incident cancer. Br J Ophthalmol. In press 2024.
    Pubmed CrossRef
  22. Monacelli F, Cea M, Borghi R, Odetti P, Nencioni A. Do cancer drugs counteract neurodegeneration? Repurposing for Alzheimer's disease. J Alzheimers Dis 2017;55:1295-306.
    Pubmed CrossRef

 

August 2024, 25 (2)